- Home
- OPAL vs NRXP Comparison
OPAL vs NRXP Comparison
Compare OPAL & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAL
- NRXP
- Stock Information
- Founded
- OPAL 1998
- NRXP 2015
- Country
- OPAL United States
- NRXP United States
- Employees
- OPAL N/A
- NRXP N/A
- Industry
- OPAL Natural Gas Distribution
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- OPAL Utilities
- NRXP Health Care
- Exchange
- OPAL Nasdaq
- NRXP Nasdaq
- Market Cap
- OPAL 78.3M
- NRXP 73.7M
- IPO Year
- OPAL N/A
- NRXP N/A
- Fundamental
- Price
- OPAL $2.06
- NRXP $2.03
- Analyst Decision
- OPAL Sell
- NRXP Strong Buy
- Analyst Count
- OPAL 4
- NRXP 5
- Target Price
- OPAL $2.81
- NRXP $31.60
- AVG Volume (30 Days)
- OPAL 210.2K
- NRXP 495.1K
- Earning Date
- OPAL 11-06-2025
- NRXP 11-17-2025
- Dividend Yield
- OPAL N/A
- NRXP N/A
- EPS Growth
- OPAL N/A
- NRXP N/A
- EPS
- OPAL 0.02
- NRXP N/A
- Revenue
- OPAL $329,243,000.00
- NRXP $242,000.00
- Revenue This Year
- OPAL $20.90
- NRXP N/A
- Revenue Next Year
- OPAL $19.44
- NRXP $395.09
- P/E Ratio
- OPAL $95.92
- NRXP N/A
- Revenue Growth
- OPAL 7.26
- NRXP N/A
- 52 Week Low
- OPAL $1.26
- NRXP $1.13
- 52 Week High
- OPAL $4.08
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- OPAL 42.30
- NRXP 30.25
- Support Level
- OPAL $2.11
- NRXP $2.04
- Resistance Level
- OPAL $2.48
- NRXP $2.81
- Average True Range (ATR)
- OPAL 0.22
- NRXP 0.21
- MACD
- OPAL -0.01
- NRXP -0.06
- Stochastic Oscillator
- OPAL 51.27
- NRXP 3.13
About OPAL OPAL Fuels Inc.
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.